"Haifeng Biomedicine" Dabigatran correction solution - Taiwan Registration 7a3bde0a72fa6c811ace2fbdc08fc916
Access comprehensive regulatory information for "Haifeng Biomedicine" Dabigatran correction solution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 7a3bde0a72fa6c811ace2fbdc08fc916 and manufactured by HYPHEN BioMed. The authorized representative in Taiwan is SYSMEX TAIWAN CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is lyophilized human plasma doped with different concentrations of Dabigatran for correction of Dabigatran measurements.
A Clinical chemistry and clinical toxicology
A.1150 Calibrated Products
QMS/QSD;; ่ผธๅ ฅ
Dates and Status
Nov 09, 2020
Nov 09, 2025

